DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan
In Brief: Interim Dean Henney Looking for Cancer Center Director; Shingleton Gets James Ewing Award
Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed
Curt, Ozols, Brown Leaving NCI; More DCT Staff Changes
DCT Board Approves Two RFAs, Changes One To PA, Kills One On Liposomes
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research
